U.S. Dry Eye Disease Diagnostic Devices Market: Introduction
According to the report, the dry eye disease diagnostic devices market in the U.S. was valued at US$ 58.3 Mn in 2020 and is projected to expand at CAGR of 4.4% from 2021 to 2031. Dry eye disease diagnostic devices include anterior segment OCT (AS-OCT), meibography device, corneal topographer, and osmolarity testing device. The usage of dry eye disease diagnostic devices can be classified based on the parameter measured into tear film osmolarity, tear turnover, functional visual acuity, tear volume, tear film stability, tear film composition, ocular biomarkers, and others.
Request Sample of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=84250
Rise in Prevalence and Incidence Rates of Dry Eye Disease in U.S.
In the U.S., dry eye disease is considered a critical and significant public health issue. An article published in the American Journal of Ophthalmology stated that the overall estimated prevalence of dry eye disease was 5.28% in the U.S. between 2003 and 2015. It also indicated that the prevalence and incidence vary from 5% to 50%, and it is rising due to higher incidence of some risk factors and gradual increase in the geriatric population. Hence, rise in prevalence of dry eye disease is anticipated to drive the market.
Rise in prevalence and incidence rates of dry eye disease and surge in geriatric population increase the risk of dry eye diseases in the U.S., which, in turn, augments the market in the country.
Request for Covid-19 Impact Analysis: https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=84250
Meibography Device Segment to Lead U.S. Dry Eye Disease Diagnostic Devices Market
In terms of device type, the dry eye disease diagnostic devices market in the U.S. has been classified into meibography device, corneal topographer, anterior segment OCT (AS-OCT), osmolarity testing device, ocular surface thermographer, interferometer, fluorophotometer, and others. The meibography device segment is expected to account for major share of the market in the U.S. in 2031. The segment is likely to expand at a CAGR of 3.8% during the forecast period. Meibomian gland disease is considered the primary cause of evaporative dry eye disease. This drives usage of meibography devices in the diagnosis of dry eye.
Enquiry Before Buying: https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=84250
Diagnostic Centers to be Key End-user
Based on end-user, the dry eye disease diagnostic devices market in the U.S. has been divided into hospitals, diagnostic centers, ophthalmology centers/clinics, and others. The diagnostic centers segment is projected to account for major share of the market in the U.S. in 2031. The segment is anticipated to expand at a CAGR of 4.5% from 2021 to 2031. Rise in prevalence of dry eye disease in the U.S., increase in ophthalmology group practice, multi-subspecialty group, single-subspecialty group, and surge in frequency of patients for diagnosis of dry eye disease in these centers propel the segment.
Key players operating in the dry eye disease diagnostic devices market in the U.S. include Johnson & Johnson Services, Inc., OCULUS Optikgeräte GmbH, Carl Zeiss Meditec AG, TearLab Corporation, Optovue, Inc., AXIM Biotechnologies, Topcon Corporation, Quantel Medical, Essilor Instruments, I-MED Pharma, Inc., Box Medical Solutions, Inc., and NIDEK CO., LTD.
U.S. Dry Eye Disease Diagnostic Devices Market: Segmentation
U.S. Dry Eye Disease Diagnostic Devices Market, by Device Type
- Anterior Segment OCT (AS-OCT)
- Meibography Device
- Corneal Topographer
- Osmolarity Testing Device
- Ocular Surface Thermographer
U.S. Dry Eye Disease Diagnostic Devices Market, by Disease
- Evaporative Dry Eye Syndrome
- Aqueous Dry Eye Syndrome
U.S. Dry Eye Disease Diagnostic Devices Market, by End-user
- Diagnostic Centers
- Ophthalmology Centers/Clinics
About Healthcare Industry at Transparency Market Research
TMR’s business intelligence reports on the healthcare sector study the dynamic ecosystems that healthcare institutions today operate in. The need to integrate next-gen technologies at every step of health services that stakeholders in the healthcare sector are subject to are deeply covered in our reports.
Our groundbreaking research covers the intricacies of managed healthcare and patient-centric solutions that make them insightful for business leaders in the healthcare sector.
About Us Section:
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453